Cargando…
Curcumin Suppresses TGF-β1-Induced Myofibroblast Differentiation and Attenuates Angiogenic Activity of Orbital Fibroblasts
Orbital fibrosis, a hallmark of tissue remodeling in Graves’ ophthalmopathy (GO), is a chronic, progressive orbitopathy with few effective treatments. Orbital fibroblasts are effector cells, and transforming growth factor β1 (TGF-β1) acts as a critical inducer to promote myofibroblast differentiatio...
Autores principales: | Yu, Wei-Kuang, Hwang, Wei-Lun, Wang, Yi-Chuan, Tsai, Chieh-Chih, Wei, Yau-Huei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268269/ https://www.ncbi.nlm.nih.gov/pubmed/34202024 http://dx.doi.org/10.3390/ijms22136829 |
Ejemplares similares
-
Essential role of connective tissue growth factor (CTGF) in transforming growth factor-β1 (TGF-β1)-induced myofibroblast transdifferentiation from Graves’ orbital fibroblasts
por: Tsai, Chieh-Chih, et al.
Publicado: (2018) -
Effect of Pirfenidone on TGF-β1-Induced Myofibroblast Differentiation and Extracellular Matrix Homeostasis of Human Orbital Fibroblasts in Graves’ Ophthalmopathy
por: Wu, Shi-Bei, et al.
Publicado: (2021) -
Increased response to oxidative stress challenge in Graves’ ophthalmopathy orbital fibroblasts
por: Tsai, Chieh-Chih, et al.
Publicado: (2011) -
The protective effect of antioxidants on orbital fibroblasts from patients with Graves’ ophthalmopathy in response to oxidative stress
por: Tsai, Chieh-Chih, et al.
Publicado: (2013) -
Alteration of Connective Tissue Growth Factor (CTGF) Expression in Orbital Fibroblasts from Patients with Graves’ Ophthalmopathy
por: Tsai, Chieh-Chih, et al.
Publicado: (2015)